Microbially derived peptides and proteins for immunotherapy
US12168676B2 · kind B2 · utility
0Cited by
3References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 6, 2020 |
| Grant date | Dec 17, 2024 |
| Priority date | — |
| Expiry date | Jan 2, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure provides therapeutic peptides and pharmaceutical compositions comprising the peptides, which have utility in treating various human diseases. In particular aspects, the disclosed therapeutic peptides are useful as immunotherapeutics for modulating regulatory and effector molecules of the mammalian immune system to mitigate disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.